Nexalin Technology (NXL) News Today $2.06 -0.03 (-1.44%) Closing price 03/27/2025 04:00 PM EasternExtended Trading$2.17 +0.11 (+5.34%) As of 03/27/2025 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on April 3March 26 at 2:46 PM | markets.businessinsider.comJoin Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on April 3March 26 at 8:30 AM | globenewswire.comNexalin Technology (NASDAQ:NXL) Raised to Buy at Maxim GroupMarch 26 at 1:31 AM | americanbankingnews.comNexalin Technology upgraded to Buy from Hold at MaximMarch 25 at 6:20 PM | markets.businessinsider.comMaxim Group Upgrades Nexalin Technology (NXL)March 24, 2025 | msn.comNexalin Technology, Inc. (NASDAQ:NXL) VP Carolyn Hamby Shelton Buys 6,000 SharesMarch 14, 2025 | insidertrades.comNexalin receives a Notice of Allowance from USPTO for patent on DIFSMarch 4, 2025 | markets.businessinsider.comNexalin Technology Receives Notice of Allowance from the USPTO for Patent Covering Deep Intracranial Frequency Stimulation (DIFS™) Technology for Opioid and Other Substance Use DisordersMarch 3, 2025 | globenewswire.comNexalin Technology Announces Initiation of Patient Recruitment for UCSD’s TBI & PTSD Clinical Study Following IRB ApprovalMarch 1, 2025 | markets.businessinsider.comNexalin Technology announces initiation of patient recruitment in UCSD studyMarch 1, 2025 | markets.businessinsider.comNexalin Technology Announces Initiation of Patient Recruitment for UCSD's TBI & PTSD Clinical Study Following IRB ApprovalFebruary 28, 2025 | globenewswire.comNexalin Technology appoints Wesley Clark to Military, Government Advisory BoardFebruary 26, 2025 | markets.businessinsider.comNexalin Technology Welcomes General Wesley Clark to Military & Government Advisory BoardFebruary 26, 2025 | globenewswire.comNexalin Technology’s HALO Clarity headset approved for use in trials by UCSDFebruary 18, 2025 | markets.businessinsider.comNexalin Technology Announces UCSD IRB Approval for use of HALO™ Clarity in Clinical Trials for mTBI and PTSD TreatmentFebruary 18, 2025 | globenewswire.comNexalin appointed industry co-chair of National TBI Registry CoalitionFebruary 10, 2025 | markets.businessinsider.comNexalin Appointed as Industry Co-Chair of National TBI Registry CoalitionFebruary 10, 2025 | globenewswire.comNexalin Technology announces effective registration statementFebruary 6, 2025 | msn.comNexalin technology's chief medical officer buys $3,100 in sharesFebruary 5, 2025 | msn.comNexalin technology's chief medical officer buys $2,980 in common stockFebruary 5, 2025 | msn.comNexalin Technology announces publication of study of DIFS technologyFebruary 3, 2025 | markets.businessinsider.comNexalin Technology, Inc. Reports Landmark Study Highlights Efficacy of DIFS™ Technology in Reducing Blood Pressure in Patients with Major Depressive DisorderFebruary 3, 2025 | quiverquant.comNexalin's Breakthrough DIFS™ Neurostimulation Device Demonstrates Reduction in Blood Pressure while Enhancing Mental Health According to New Landmark StudyFebruary 3, 2025 | globenewswire.comNexalin technology's chief medical officer buys $4,050 in stockJanuary 30, 2025 | msn.comNexalin technology's chief medical officer buys $7,700 in stockJanuary 24, 2025 | msn.comJoin Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session, Today, January 23January 23, 2025 | finance.yahoo.comJoin Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session, Today, January 23January 23, 2025 | globenewswire.comNexalin Technology, Inc.: Nexalin Technology CEO Mark White Issues Letter to Shareholders Highlighting Recent Achievements and Outlook for 2025January 14, 2025 | finanznachrichten.deNexalin Technology CEO Mark White Issues Letter to Shareholders Highlighting Recent Achievements and Outlook for 2025January 14, 2025 | markets.businessinsider.comNexalin Technology Completes Phase 1of its Innovative Virtual ClinicDecember 23, 2024 | globenewswire.comMaxim Group Downgrades Nexalin Technology (NXL)December 6, 2024 | msn.comShort Interest in Nexalin Technology, Inc. (NASDAQ:NXL) Drops By 51.7%Nexalin Technology, Inc. (NASDAQ:NXL - Get Free Report) was the target of a significant decrease in short interest in the month of November. As of November 15th, there was short interest totalling 622,600 shares, a decrease of 51.7% from the October 31st total of 1,290,000 shares. Approximately 6.3% of the company's shares are sold short. Based on an average daily volume of 1,580,000 shares, the short-interest ratio is currently 0.4 days.November 28, 2024 | marketbeat.comNew Peer-Reviewed Publication Validates Nexalin's Deep Intracranial Frequency Stimulation (DIFS) Technology, Reinforcing Leadership in High-Growth Neuromodulation MarketNovember 26, 2024 | globenewswire.comNexalin Technology releases letter to shareholdersNovember 12, 2024 | markets.businessinsider.comIs Nexalin Technology (NASDAQ:NXL) In A Good Position To Invest In Growth?November 10, 2024 | finance.yahoo.comNexalin Technology’s Strong Financial Position: No Defaults on Senior SecuritiesNovember 10, 2024 | markets.businessinsider.comNexalin Technology regains compliance with Nasdaq continued listing rulesNovember 2, 2024 | markets.businessinsider.comJoin Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on November 5thNovember 2, 2024 | markets.businessinsider.comJoin Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on November 5thNovember 1, 2024 | globenewswire.comNexalin Technology Regains Compliance with Nasdaq Continued Listing RequirementsNovember 1, 2024 | globenewswire.comEXCLUSIVE: Nexalin Technology Says New Data Confirms Investigational Non-Invasive Neurostimulation Device Improves Cognitive Function, Restores Brain Activity in Alzheimer's ...October 29, 2024 | msn.comNexalin Technology Announces Landmark Study on Alzheimer's Disease and Deep Intracranial Frequency Stimulation Published in Journal of Alzheimer's DiseaseOctober 28, 2024 | globenewswire.comNexalin announced planned clinical trial utilizing Gen-3 Halo headsetOctober 23, 2024 | markets.businessinsider.comNexalin Technology Announces Planned Clinical Trial Utilizing Gen-3 Halo Headset in Partnership with UC San Diego & San Diego VAOctober 22, 2024 | globenewswire.comEXCLUSIVE: Nano-Cap Nexalin's Drug-Free Alternative For Alzheimer's Shows Improved Memory, Cognitive Function In Small StudyOctober 18, 2024 | msn.comNew Study Shows Nexalin's Deep Intracranial Frequency Stimulation (DIFS) Significantly Improves Memory and Cognitive Function in Alzheimer's PatientsOctober 17, 2024 | globenewswire.comNexalin Technology Appoints Carolyn Shelton as Senior Vice President of Clinical, Quality & Regulatory AffairsOctober 14, 2024 | globenewswire.comMaxim Group Initiates Coverage of Nexalin Technology (NXL) with Buy RecommendationOctober 10, 2024 | msn.comNexalin Technology (NASDAQ:NXL) Stock Quotes, Forecast and News SummaryOctober 10, 2024 | benzinga.comNexalin Technology (NASDAQ:NXL) Stock, Short Interest ReportOctober 5, 2024 | benzinga.com Remove Ads Get Nexalin Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for NXL and its competitors with MarketBeat's FREE daily newsletter. Email Address NXL Media Mentions By Week NXL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NXL News Sentiment▼0.640.85▲Average Business Services News Sentiment NXL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NXL Articles This Week▼81▲NXL Articles Average Week Remove Ads Get Nexalin Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for NXL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies InfuSystem News TELA Bio News Hyperfine News Zynex News Lucid Diagnostics News FONAR News Edap Tms News IceCure Medical News InspireMD News Sensus Healthcare News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NXL) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersA $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOWExpert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legen...Stansberry Research | SponsoredElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nexalin Technology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nexalin Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
